Compare Moderna, Inc. (MRNA) vs SkyWest Inc (SKYW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs SkyWest Inc — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while SkyWest Inc trades at $95.26 (market cap $3.94B). The key difference: Moderna, Inc. is far larger — about 6× SkyWest Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, SkyWest Inc nearer its low. Which is the better fit depends on your goals.
| MRNA | SKYW | |
|---|---|---|
Market Cap | $23.60B | $3.94B |
Sector | Health | Technology |
52-Week High | $81.80 | $123.72 |
52-Week Low | $22.36 | $78.40 |
Enterprise Value | $19.70B | $5.79B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About SkyWest Inc
SkyWest, Inc. is a major North American regional airline company, operating primarily through its subsidiary, SkyWest Airlines. The company provides regional airline service to various large airlines under contract, including United Airlines (as United Express), Delta Air Lines (as Delta Connection), American Airlines (as American Eagle), and Alaska Airlines (as Alaska SkyWest). SKYW's primary business is providing essential flight services, connecting smaller cities to major airline hubs across the United States.
Read more on SKYW →
